The use of dopamine agonists during pregnancy is generally avoided unless absolutely necessary. If a woman becomes pregnant while on dopamine agonists, the medication is usually discontinued unless the risks of untreated hyperprolactinemia outweigh the potential risks to the fetus. Close monitoring by a healthcare provider is essential in such cases.
